KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 128 filers reported holding KEZAR LIFE SCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $43,933 | -67.9% | 14,036 | -27.8% | 0.02% | -66.2% |
| Q4 2022 | $136,766 | -28.4% | 19,427 | -12.2% | 0.07% | -6.6% |
| Q3 2022 | $191,000 | +4.9% | 22,136 | +0.8% | 0.08% | +13.4% |
| Q2 2022 | $182,000 | -12.5% | 21,970 | +75.2% | 0.07% | -28.0% |
| Q1 2022 | $208,000 | -6.3% | 12,543 | -5.6% | 0.09% | +10.7% |
| Q4 2021 | $222,000 | -31.5% | 13,289 | -75.5% | 0.08% | -38.7% |
| Q1 2021 | $324,000 | +16.5% | 54,313 | +1.8% | 0.14% | +19.1% |
| Q4 2020 | $278,000 | -9.7% | 53,348 | -16.2% | 0.12% | -29.0% |
| Q3 2020 | $308,000 | -17.9% | 63,689 | -12.0% | 0.16% | -9.0% |
| Q2 2020 | $375,000 | – | 72,378 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 4,770,799 | $5,677,251 | 1.80% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $986,166 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,167,591 | $8,529,433 | 0.46% |
| SPHERA FUNDS MANAGEMENT LTD. | 2,051,676 | $2,441,494 | 0.44% |
| Avidity Partners Management LP | 6,011,100 | $7,153,209 | 0.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 703,825 | $830,514 | 0.28% |
| Opaleye Management Inc. | 425,000 | $505,750 | 0.16% |
| Orbimed Advisors | 5,463,000 | $6,500,970 | 0.14% |
| Ikarian Capital, LLC | 853,391 | $1,015,535 | 0.12% |
| Palo Alto Investors LP | 656,200 | $780,878 | 0.07% |